Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA), ...
TipRanks on MSN
Ultragenyx completes BLA filing for GSDIa gene therapy
Ultragenyx Pharmaceutical ( ($RARE) ) just unveiled an update. On December 30, 2025, Ultragenyx Pharmaceutical announced it had completed the ...
The report cites tightening emissions standards and incentives as primary adoption drivers, particularly for urban delivery and municipal fleets.
Evodrop reports steady progress in water treatment through certified systems, expanded installations, and sustained market ...
Historically, lithium has been produced using two approaches: hard rock mining of spodumene deposits, as seen at the ...
Morning Overview on MSN
A tiny new chip design could accelerate quantum progress
Quantum computing has long promised breakthroughs in chemistry, logistics, finance, and climate modeling, but the hardware ...
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) ...
For nearly three decades, the International Space Station has been the only destination in low Earth orbit, but that will ...
Learners are taught by local and international university professors and get access to industry experts to expand networks. Credits are earned as part of ...
The world’s energy demand is rising, and NREL’s ULIS power module could help meet it. Demand for energy worldwide is climbing rapidly, driven in part by power hungry data centers that support ...
Tech Xplore on MSN
New calibration module offers improved measurement of thermoelectric device performance
A standard reference thermoelectric module (SRTEM) for objectively measuring thermoelectric module performance has been ...
Looking for AI tools to help with studies and assignments? Here are my picks for the best AI tools for students after testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results